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A B S T R A C T
Background: Surgical treatment of brain tumors were proved to be at highest risk of unplanned reoperation.
Therefore, we decided to find possible predictors of complications leading to early unplanned reoperations
among patients with supratentorial brain tumors.
Methods: We retrospectively analysed 328 patients who underwent craniotomy due to supratentorial brain
tumor. Early reoperation was defined as reoperation during the same hospital stay. To determine the potential
predictors of early reoperation we used univariate and multivariate logistic regression analyses.
Results: A total of 22 (6.51%) patients underwent unplanned reoperation. Those patients significantly more
often were diagnosed with high grade glioma (81.82% vs. 55.70%; p=0.02). They had lower Red Blood Cells
count (4.16 ± 0.82 vs. 4.60 ± 0.56 103/μl; p < 0.01) and haemoglobin (12.58 ± 2.46 vs. 13.7 ± 1.72 g/dl;
p < 0.01) and lower haematocrit (36.93 ± 6.84 vs. 39.94 ± 4.66%; p < 0.01) preceding surgery. Surgeries
of reoperated patients more often were performed during “on call” hours (17.65% vs. 4.49%; p=0.02). After
adjustment for possible confounders frontal craniotomy (OR: 2.961; 95% CI: 1.042–8.406; p=0.04)and “on
call” hours of surgery (OR: 2.961; 1.042–8.406; p=0.04) remained independently associated with higher risk of
reoperation.
Conclusions: Frontal craniotomy and surgery during “on call” hours are independently associated with higher
risk of reoperation in supratentorial brain tumors.
1. Introduction
Unplanned reoperations constitute a significant part of complica-
tions in all of surgical specialties [1–4]. They are considered as im-
portant quality indicator and can be associated with significant eco-
nomic burden [5]. In terms of neurosurgery, among all possible causes
of operation brain tumors were proved to be at highest risk of un-
planned reoperation both in children and adults [6–8]. Postoperative
complications were shown to be associated with higher mortality [9,10]
and postoperative haemorrhage established as most frequent cause of
death [11]. Unplanned reoperation is also linked with prolonged hos-
pitalization [9]. Reoperation rate among patients with brain tumors
varies between 2 and 11% and most commonly indicated risk factors
are clotting disorders, older age and infratentorial location [9,10,12].
However, there are still many inaccuracies in terms of other predictors
especially that, due to our knowledge, there are limited studies ana-
lysing only intrinsic supratentorial tumors. Therefore, we decided to
find possible predictors of complications leading to early unplanned
reoperations among patients with supratentorial brain tumors. We also
aimed at establishing rate of early unplanned reoperations for those
patients.
2. Methods and materials
We retrospectively analysed 328 patients who underwent cra-
niotomy due to supratentorial brain tumor operated in department of
neurosurgery between January of 2015 and December of 2016. From
their medical record we obtained detailed medical history which in-
cluded chronic diseases and current medications. We also obtained
blood test results taken within 24 h before surgery together with details
concerning operation such as its date, duration, cause, type and side of
craniotomy and whether doctor who performed surgery and their as-
sistant were specialist in neurosurgery or neurosurgeon in training.
Additionally, we obtained details about tumors such as its location,
histological type and whether complete removal was achieved. Early
unplanned reoperation was defined as reoperation that occurred during
the same hospitalization. Study protocol was approved by local bioe-
thical committee.
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2.1. Statistical analysis
To perform statistical analysis we used χ2 test for proportional
values and t-Student test and Mann-Whitney U test as appropriate for
continuous variables. To determine the potential predictors of re-
operation after supratentorial brain tumor removal we used univariate
and multivariate logistic regression analysis. P-values < 0.05 were
considered to be statistically significant. Threshold of p-value < 0.1
was used to qualify date to multivariate logistic regression analysis.
Forward logistic regression analysis was followed by backwards logistic
regression analysis. To perform all statistical analysis we used STATI-
STICA v. 10 for Windows (Statsoft, Poland).
3. Results
3.1. Study group characteristics
Our study group consisted of 328 patients and 164 of them
(46.19%) of them were females. Mean age of study group was
58.61 ± 13.73 years. Details concerning demographic data and past
medical history and current medications are presented in Table 1. The
most common histological type of tumor was high grade glioma
(57.39%), then metastatic tumor (26.33%) and low grade glioma
(16.27%). Thirty-nine (11.54%) of tumors were recurrent. The most
common tumor location was frontal lobe (41.48%), then temporal lobe
(39.77%), occipital lobe (11.36%), intraventricular location (3.41%),
insula (1.70%), parietal lobe (1.14%) and pineal gland (1.14%). One
hundred twenty-five (36.98%) of tumors were in cortical location
(Table 2).
3.2. Unplanned reoperations
A total of 22 (6.51%) patients underwent unplanned reoperation.
Those patients significantly more often had hypercholesterolemia
(9.09% vs. 1.90%; p= 0.03) and were diagnosed with high grade
glioma (81.82% vs. 55.70%; p= 0.02). In preoperative blood test re-
sults they had lower Red Blood Cells (RBC) count (4.16 ± 0.82 vs.
4.60 ± 0.56 103/μl; p < 0.01) and haemoglobin (12.58 ± 2.46 vs.
13.7 ± 1.72 g/dl; p < 0.01), higher Mean Corpuscular Volume
(89.11 ± 3.46 vs. 87.08 ± 4.71 μm3; p= 0.05) and lower
Table 1
Detailed characteristics of patients that underwent reoperation and control group.
Reoperation
(n= 22)
No reoperation
(n= 306)
p-value
Age [years] ± SD 60.18 ± 11.89 58.51 ± 13.88 0.58
Female gender [%] 50.00 (11) 48.42 (153) 0.89
Medical history
Hypertension [%] 36.36 (8) 33.54 (106) 0.79
Diabetes mellitus [%] 9.09 (2) 15.19 (48) 0.44
Cigarette smoking [%] 18.18 (4) 19.62 (62) 0.87
Alcohol abuse [%] 4.55 (1) 9.18 (29) 0.46
Ischemic heart disease [%] 9.09 (2) 2.85 (9) 0.11
History of heart attack [%] 0 (0) 2.22 (7) 0.48
History of ischemic stroke [%] 0 (0) 4.11 (13) 0.33
Atrial fibrillation [%] 0 (0) 1.58 (5) 0.55
Lungs diseases [%] 0 (0) 0.95 (3) 0.65
Hyperthyroidism [%] 0 (0) 0.95 (3) 0.65
Hypothyroidism [%] 0 (0) 2.22 (7) 0.48
Hypercholesterolemia [%] 9.09 (2) 1.90 (6) 0.03
Current medications
Acetylsalicylic acid [%] 0 (0) 3.48 (11) 0.37
Beta-blockers [%] 4.55 (1) 9.49 (30) 0.44
Angiotensin-converting-enzyme inhibitors [%] 18.18 (4) 12.97 (41) 0.49
AT2-blockers [%] 0 (0) 0.63 (2) 0.71
Calcium channel blockers [%] 0 (0) 6.33 (20) 0.22
Diuretics [%] 9.09 (2) 13.92 (44) 0.52
Steroids [%] 9.09 (2) 15.19 (48) 0.44
Antidiabetic therapy [%] 0 (0) 5.06 (16) 0.28
Insulin [%] 0 (0) 2.22 (7) 0.48
Heparin [%] 0 (0) 4.75 (15) 0.30
Anticoagulants [%] 0 (0) 2.85 (9) 0.42
Nitrates [%] 0 (0) 0.32 (1) 0.79
Statins [%] 0 (0) 1.27 (4) 0.60
Blood test results preceding surgery
Red Blood Cells count [103/μl] ± SD 4.16 ± 0.82 4.6 ± 0.56 < 0.01
White Blood Cells count [103/μl] ± SD 10.00 ± 6.48 10.85 ± 5.07 0.46
Platelets count [103/μl] ± SD 219.64 ± 62.24 243.65 ± 74 0.14
Haemoglobin [g/dl] 12.58 ± 2.46 13.7 ± 1.72 < 0.01
Activated Partial Prothrombin Time [s] ± SD 27.52 ± 3.4 26.74 ± 3.91 0.39
International Normalized Ratio ± SD 1.02 ± 0.08 1 ± 0.08 0.25
Creatinine [μmol/l] ± SD 64.48 ± 24.52 71.71 ± 16.85 0.07
Glucose [mmol/l] ± SD 6.98 ± 2.41 6.2 ± 2.05 0.10
Mean Corpuscular Volume [μm3] ± SD 89.11 ± 3.46 87.08 ± 4.71 0.05
Mean Corpuscular Haemoglobin [pg] ± SD 30.3 ± 1.48 29.85 ± 1.83 0.26
Mean Corpuscular Haemoglobin Concentration [g/dl] ± SD 34.02 ± 1.05 34.27 ± 1.12 0.30
Urea [mmol/l] ± SD 6.69 ± 2.74 6.92 ± 2.94 0.73
Sodium [mmol/l] ± SD 139.82 ± 4.49 139.12 ± 3.61 0.39
Potassium [mmol/l] ± SD 4.16 ± 0.5 4.35 ± 0.43 0.06
Prothrombin Time [s] ± SD 11.74 ± 0.95 11.55 ± 0.82 0.36
Haematocrit [%] ± SD 36.93 ± 6.84 39.94 ± 4.66 < 0.01
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haematocrit (36.93 ± 6.84 vs. 39.94 ± 4.66%; p < 0.01). Surgeries
of reoperated patients significantly more often were performed during
“on call” hours (17.65% vs. 4.49%; p= 0.02). There was no significant
difference in terms of tumor location. After adjustment for possible
confounders frontal craniotomy (OR: 2.961; 95% CI: 1.042–8.406;
p=0.04 and “on call” hours of surgery (OR: 4.843; 95% CI:
1.101–21.286; p=0.04) remained independently associated with
higher risk of early reoperation in patients with supratentorial brain
tumor.
3.3. Causes of unplanned reoperations
The most common cause of unplanned reoperations was cere-
brospinal fluid leak (50%), then postoperative haemorrhage (27.27%),
wound infection (13.64%) and brain edema (9.09%). The distribution
of cause of reoperation according to the histopathological type of tumor
is shown in Fig. 1.
4. Discussion
In this single center retrospective study we established frequency
and possible predictors of early unplanned reoperations in supra-
tentorial tumors.
In our study we established complication rate at about 6.5%. Lower
rates were established by Dasenbrock et al. (3%) [9] and McLaughlin
et al. (2%) [8]. Lonjaret et al. in their study found that about 11% of
patients underwent reoperation [13] and Kageji et al. and Lassen et al.
established rate of reoperation due to postoperative haemorrhage at
about 2% [10,12]. In terms of pediatric neurosurgery Lassen et al.
found that 0.4% of patients were reoperated due to postoperative
haemorrhage and about 7% due to cerebrospinal fluid (CSF) leak [14].
An interesting finding in our study was independent association
between surgeries performed during “on call” hours and higher risk of
reoperation. Emergency brain tumor surgeries have also been de-
termined as predictor of reoperation in Dasebrock et al. study [9]. Si-
milar results were also observed by Nittiby et al. and Rolston et al. in
terms of all neurosurgical procedures [15,16] and by Desai et al. in
terms of pediatric neurosurgery [17]. In addition, emergency surgeries
can be a risk factor of postoperative complications in general surgery
[18] and cardiac surgery [1]. An explanation of those association can be
the fact that patients operated after-hours are usually in worse general
condition. Patients that are qualified for emergency tumor surgery
usually present with increased intracranial pressure (ICP) or in-
tracranial haemorrhage, which could affect postoperative complica-
tions. Also, night-time surgery can be more demanding for neuro-
surgeon. However, in other surgical specialties, surgeries performed
during night were not associated with higher risk of poor treatment
outcome [19].
Another finding of our study is significantly lower RBC count and
haemoglobin in reoperated patients, as well as lower haematocrit and
higher MCV. Those results indicate presence of anemia among re-
operated patients prior to the initial surgery. Many researchers showed
impact of preoperative anemia on mortality and postoperative com-
plications in other surgical specialties [2,6,9,17,18,20–24]. In terms of
neurosurgery, preoperative anemia was associated with higher mor-
tality and risk of complications among patients who underwent elective
cranial procedures [25,26]. Alan et al. in their study found that for
patients with brain tumor anemia is a risk factor of prolonged hospital
stay [27]. It was also linked with higher risk of infection after spinal
surgery [28]. To explain those correlation other researchers suggested
that anemia could indicate an underlying disease process [25,27]. It
was also shown that it can cause changes in oxygen extraction ratio and
regional blood flow in the brain [27,29]. Additionally, in terms of
haematocrit, Lassen et al. found that patients with brain tumor who had
lower haematocrit were at higher risk of postoperative morbidity [12].
Our study also showed that patients with high grade glioma are at
higher risk of early reoperation, particularly due to a haemorrhage.
Although other researchers have examined association between histo-
logical type of tumor and risk of reoperation, none of them found such
correlation [9–13]. Fact that high grade gliomas growth is associated
with increased angiogenesis [22] could explain such correlation.
We also found that frontal craniotomy was independently associated
with higher risk of early reoperation. That correlation was also showed
in our previous study, concerning all neurosurgical procedures [7],
however it was not confirmed by any other researcher [9–13]. As we
suggested in previous study, that association can be explained by the
fact that during frontal craniotomy frontal sinuses might be opened,
which could increase risk of postoperative infection [30].
Another finding of our study was higher risk of emergency re-
operation in patient with hypercholesterolemia. None of other re-
searchers found similar association [9–13]. We interpret this finding as
a coincidence.
Our study was limited by fact that obtained data come from single
neurosurgical facility experience. Further research should be performed
as multi-centre study. Despite those limitation, we were able to analyse
full range of possible complications requiring reoperation after supra-
tentorial, intrinsic brain tumor surgeries during two years time period.
5. Conclusions
Patients with lower RBC count and haemoglobin, as well as with
higher MCV and lower haematocrit are at higher risk of early re-
operation after brain tumor surgery. Higher risk of emergency re-
operation is also associated with surgery of high grade glioma. Frontal
craniotomy and surgery during “on call” hours are independently as-
sociated with higher risk of complications requiring reoperation after
Table 2
Details concerning type of surgery and treated tumor characteristic.
Reoperation
(n=22)
No reoperation
(n= 306)
p-value
Surgery during weekend [%] 27.27 (6) 16.14 (51) 0.18
“On call” hours of surgery [%] 17.65 (3) 4.49 (12) 0.02
Surgery duration [min] ± SD 115.24 ± 67.49 138.58 ± 66.23 0.16
Bone flap removal [%] 36.36 (8) 20.57 (65) 0.08
Operating specialist 90.91 (20) 84.81 (268) 0.44
Asysting specialist 36.36 (8) 40.51 (128) 0.70
Lineal incision [%] 4.55 (1) 4.43 (14) 0.98
Craniotomy type
Pterional [%] 0 (0) 1.58 (5) 0.55
Frontal [%] 50.00 (11) 31.33 (99) 0.07
Temporal [%] 18.18 (4) 7.91 (25) 0.10
Parietal [%] 4.55 (1) 17.09 (54) 0.12
Parieto-occipital [%] 9.09 (2) 9.81 (31) 0.91
Fronto-parietal [%] 0 (0) 9.18 (29) 0.14
Fronto-temporo-parietal [%] 9.09 (2) 12.97 (41) 0.60
Suboccipital [%] 0 (0) 4.75 (15) 0.30
Right side [%] 63.64 (14) 56.65 (179) 0.52
Left side [%] 54.55 (12) 55.70 (176) 0.92
Tumor location
Frontal lobe [%] 13.64 (3) 22.15 (70) 0.35
Temporal lobe [%] 31.82 (7) 19.94 (63) 0.18
Parietal lobe [%] 0 (0) 0.63 (2) 0.71
Occipital lobe [%] 4.55 (1) 6.01 (19) 0.78
Insula [%] 0 (0) 0.95 (3) 0.65
Intraventricular [%] 0 (0) 1.90 (6) 0.51
Pineal gland [%] 0 (0) 0.63 (2) 0.71
Cortical [%] 22.73 (5) 37.97 (120) 0.15
Subcortical [%] 77.27 (17) 62.03 (196) 0.15
Tumor characteristics
Subtotal resection [%] 0 (0) 5.70 (18) 0.25
Recurrent tumor [%] 22.73 (5) 10.76 (34) 0.09
High Grade glioma [%] 81.82 (18) 55.70 (176) 0.02
Low Grade glioma [%] 4.55 (1) 17.09 (54) 0.12
Metastatic tumor [%] 13.64 (3) 27.22 (86) 0.16
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supratentorial brain tumor surgery.
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